| Source: |
| Type: |
| AntiTumor |
| 3869- | Carno, | Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 4477- | Chit, | Recent Advances in Chitosan and its Derivatives in Cancer Treatment |
| - | Review, | NA, | NA |
| 4487- | Chit, | PreB, | Unravelling the Role of Chitin and Chitosan in Prebiotic Activity and Correlation With Cancer: A Narrative Review |
| - | Review, | NA, | NA |
| 1600- | Cu, | Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis |
| - | Review, | NA, | NA |
| 1843- | dietFMD, | BTZ, | Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia |
| - | in-vivo, | CLL, | NA |
| 4983- | Dipy, | ATV, | Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one |
| - | Review, | Var, | NA |
| 4914- | DSF, | immuno, | Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies |
| - | Review, | Var, | NA |
| 5007- | DSF, | Cu, | Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma |
| - | vitro+vivo, | Oral, | NA |
| - | vitro+vivo, | lymphoma, | NA |
| 1037- | EA, | Unripe Black Raspberry (Rubus coreanus Miquel) Extract and Its Constitute, Ellagic Acid Induces T Cell Activation and Antitumor Immunity by Blocking PD-1/PD-L1 Interaction |
| - | in-vivo, | CRC, | NA |
| 4685- | EGCG, | Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines |
| - | in-vitro, | NPC, | TW01 | - | in-vitro, | NPC, | TW06 |
| 3593- | EGCG, | Epigallocatechin Gallate (EGCG) |
| - | Review, | AD, | NA |
| 1112- | FA, | Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | BC, | NA |
| 1954- | GamB, | Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase |
| - | in-vitro, | HCC, | SMMC-7721 cell |
| 1969- | GamB, | Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
| 2523- | H2, | Prospects of molecular hydrogen in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2522- | H2, | A Systematic Review of Molecular Hydrogen Therapy in Cancer Management |
| - | Review, | Var, | NA |
| 3152- | H2, | VitC, | Rad, | Hydrogen and Vitamin C Combination Therapy: A Novel Method of Radioprotection |
| - | in-vitro, | Nor, | HUVECs | - | in-vivo, | NA, | NA |
| 4645- | HT, | Hydroxytyrosol: Bioavailability, toxicity, and clinical applications |
| - | Review, | NA, | NA |
| 1088- | IP6, | Preventive Inositol Hexaphosphate Extracted from Rice Bran Inhibits Colorectal Cancer through Involvement of Wnt/β-Catenin and COX-2 Pathways |
| - | in-vivo, | CRC, | NA |
| 2543- | M-Blu, | The use of methylene blue to control the tumor oxygenation level |
| - | in-vivo, | Lung, | NA |
| 4528- | MAG, | Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update |
| - | Review, | Nor, | NA |
| 4526- | MAG, | HNK, | Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis |
| - | Review, | Var, | NA |
| 1786- | MEL, | What is known about melatonin, chemotherapy and altered gene expression in breast cancer (Review) |
| - | Review, | NA, | NA |
| 3464- | MF, | Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology |
| - | Review, | Var, | NA |
| 3837- | Moringa, | Moringa oleifera: A Tree of Life as a Promising Medicinal Plant for Neurodegenerative Diseases |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 5604- | NaHCO3, | Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity |
| - | vitro+vivo, | Melanoma, | B16-BL6 | - | in-vitro, | BC, | 4T1 |
| 1797- | NarG, | Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway |
| - | in-vitro, | BC, | MDA-MB-231 |
| 1807- | NarG, | A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies |
| - | Review, | NA, | NA |
| 4627- | OLE, | Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity |
| - | in-vitro, | Oral, | NA |
| 1811- | Oxy, | Hyperbaric oxygen therapy and cancer—a review |
| - | Review, | NA, | NA |
| 2037- | PB, | Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria |
| - | in-vitro, | GBM, | NA | - | in-vivo, | GBM, | NA |
| 3000- | PL, | Biological and physical approaches on the role of piplartine (piperlongumine) in cancer |
| - | in-vitro, | Nor, | HUVECs | - | in-vitro, | Laryn, | HEp2 |
| 4965- | PSO, | Cisplatin, | The synergistic antitumor effects of psoralidin and cisplatin in gastric cancer by inducing ACSL4-mediated ferroptosis |
| - | vitro+vivo, | GC, | HGC27 | - | vitro+vivo, | GC, | MKN45 |
| 4968- | PSO, | Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer |
| - | in-vitro, | Cerv, | NA |
| 4693- | PTS, | Pterostilbene in the treatment of inflammatory and oncological diseases |
| 3601- | QC, | Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 891- | QC, | Chapter 9 - Quercetin: Prooxidant Effect and Apoptosis in Cancer |
| - | in-vitro, | Var, | NA |
| 2300- | QC, | Flavonoids Targeting HIF-1: Implications on Cancer Metabolism |
| - | Review, | Var, | NA |
| 882- | RES, | Resveratrol: A Double-Edged Sword in Health Benefits |
| - | Review, | NA, | NA |
| 871- | RES, | CUR, | QC, | The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | BC, | 4T1 |
| 2440- | RES, | Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway |
| - | in-vitro, | Lung, | H460 | - | in-vivo, | Lung, | NA | - | in-vitro, | Lung, | H1650 | - | in-vitro, | Lung, | HCC827 |
| 4357- | RF, | Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies |
| - | Review, | Var, | NA |
| 4909- | Sal, | Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model |
| - | vitro+vivo, | CRC, | NA |
| 4486- | Se, | Chit, | Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis |
| - | in-vitro, | Liver, | HepG2 |
| 4745- | SeNPs, | Chemo, | Translational Selenium Nanoparticles Promotes Clinical Non-small-cell Lung Cancer Chemotherapy via Activating Selenoprotein-driven Immune Manipulation |
| - | Study, | NSCLC, | NA |
| 4608- | SeNPs, | Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics |
| - | Review, | Var, | NA | - | NA, | AD, | NA |
| 4491- | SeNPs, | Chit, | VitC, | Synthesis of a Bioactive Composition of Chitosan–Selenium Nanoparticles |
| - | Study, | NA, | NA |
| 4469- | SeNPs, | Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential |
| - | Review, | Var, | NA |
| 1061- | SFN, | Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors |
| - | vitro+vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:913 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid